Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: Reversal by glycine and a glycine transporter inhibitor

Biological Psychiatry

Volumn 54, Issue 11, 2003, Pages 1162-1170

  Le Pen, Gwenaëlle ^a,d   Kew, James ^b   Alberati, Daniela ^c   Borroni, Edilio ^c   Heitz, Marie Paule ^c   Moreau, Jean Luc ^c  

^a CENTRE PAUL BROCA   (France)

^b GLAXOSMITHKLINE   (United Kingdom)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d INSERM   (France)

Author keywords

Glycine; Hippocampus; Neonatal lesion; Prepulse inhibition; Schizophrenia

Indexed keywords

GLYCINE; GLYCINE TRANSPORTER 1 INHIBITOR; IBOTENIC ACID; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; EXPERIMENTAL RAT; HIPPOCAMPUS; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STARTLE REFLEX; STIMULUS RESPONSE;

EID: 0344430085     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00374-3     Document Type: Article

References (100)

1. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci. 16:1996;19-30.
2. Al-Amin H.A., Weinberger D.R., Lipska B.K. Exaggerated MK-801-induced motor hyperactivity in rats with neonatal lesion of the ventral hippocampus. Behav Pharmacol. 11:2000;269-278.
3. Al-Amin H.A., Weinberger D.R., Lipska B.K. Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry. 49:2001;528-539.
4. Aparicio-Legarza M.I., Cutts A.J., Davis B., Reynolds G.P. Deficits of. [3H]D-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia Neurosci Lett. 232:1997;13-16.
5. Bakshi V.P., Geyer M.A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;198-201.
6. Bakshi V.P., Geyer M.A. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci. 18:1998;8394-8401.
7. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 271:1994;787-794.
8. Ban T.A., Guy W., Wilson W.H. Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification. Psychiatr Dev. 2:1984;179-199.
9. Bartha R., Williamson P.C., Drost D.J., Malla A., Carr T.J., Cortese L., et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 54:1997;959-965.
10. Becker A., Grecksch G. Social memory is impaired in neonatally ibotenic acid lesioned rats. Behav Brain Res. 109:2000;137-140.
11. Becker A., Grecksch G., Berstein H.-G., Höllt V., Bogerts B. Social behaviour in rats lesioned with ibotenic acid in the hippocampus Quantitative and qualitative analysis . Psychopharmacology. 144:1999;333-338.
12. Bernstein H.G., Grecksch G., Becker A., Hollt V., Bogerts B. Cellular changes in rat brain areas associated with neonatal hippocampal damage. Neuroreport. 10:1999;2307-2311.
13. Black M.D., Lister S., Hitchcock J.M., Van Giersbergen P., Sorensen S.M. Neonatal hippocampal lesion model of schizophrenia in rats Sex differences and persistence of effects into maturity . Drug Dev Res. 43:1998;206-213.
14. Bouwmeester H., Wolterink G., van Ree J.M. Neonatal development of projections from the basolateral amygdala to prefrontal, striatal, and thalamic structures in the rat. J Comp Neurol. 442:2002;239-249.
15. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
16. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle Normal subjects, patient groups, and pharmacological studies . Psychopharmacology. 156:2001;234-258.
17. Brake W.G., Sullivan R.M., Flores G., Srivastava L.K., Gratton A. Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress An electrochemical study in the adult rat . Brain Res. 831:1999;25-32.
18. Brog J.S., Salyapongse A., Deutch A.Y., Zahm D.S. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum Immunohistochemical detection of retrogradely transported fluoro-gold . J Comp Neurol. 338:1993;255-278.
19. Brown A., Carlyle I., Clark J., Hamilton W., Gibson S., McGarry G., et al. Discovery and SAR of org 24598 - a selective glycine uptake inhibitor. Bioorg Med Chem Lett. 11:2001;2007-2009.
20. Carlsson M., Carlsson A. Schizophrenia A subcortical neurotransmitter imbalance syndrome? Schizophr Bull. 16:1990;425-432.
21. Chambers R.A., Moore J.M., McEvoy J.P., Levin E.D. Cognitive effects of neonatal hippocampal lesions in rat model of schizophrenia. Neuropsychopharmacology. 15:1996;587-594.
22. Contreras P.C. D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology. 29:1990;291-293.
23. Coyle J.T. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry. 3:1996;241-253.
24. Daenen E.W., Van der Heyden J.A., Kruse C.G., Wolterink G., Van Ree J.M. Adaptation and habituation to an open field and responses to various stressful events in animals with neonatal lesions in the amygdala or ventral hippocampus. Brain Res. 918:2001;153-165.
25. Deacon T.W., Eichenbaum H., Rosenberg P., Eckmann K.W. Afferent connections of the perirhinal cortex in the rat. J Comp Neurol. 220:1983;168-190.
26. Ellenbroek B.A., van den Kroonenberg P.T., Cools A.R. The effects of an early stressful life event on sensorimotor gating in adult rats. Schizophr Res. 30:1998;251-260.
27. Evins A.E., Amico E., Posever T.A., Toker R., Goff D.C. D-cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia. Schizophr Res. 56:2002;19-23.
28. Feinberg I. Cortical pruning and development of schizophrenia. Schizophr Bull. 16:1990;567-570.
29. Fendt M., Schwienbacher I., Koch M. Amygdaloid N-methyl-D-aspartate and gamma-aminobutyric acid(A) receptors regulate sensorimotor gating in a dopamine-dependent way in rats. Neuroscience. 98:2000;55-60.
30. Fink J.S. Neurobiology of basal ganglia receptors. Clin Neurosci. 1:1993;27-35.
31. Fishkin R.J., Ince E.S., Carlezon W.A. Jr, Dunn R.W. D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats. Behav Neural Biol. 59:1993;150-157.
32. Flores G., Barbeau D., Quirion R., Srivastava L.K. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J Neurosci. 16:1996;2020-2026.
33. Gao X.M., Sakai K., Roberts R.C., Conley R.R., Dean B., Tamminga C.A. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus Effects of schizophrenia . Am J Psychiatry. 157:2000;1141-1149.
34. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia A decade in review . Psychopharmacology. 156:2001;117-154.
35. Gomez-Serrano M., Tonelli L., Listwak S., Sternberg E., Riley A.L. Effects of cross fostering on open-field behavior, acoustic startle, lipopolysaccharide-induced corticosterone release, and body weight in Lewis and Fischer rats. Behav Genet. 31:2001;427-436.
36. Goto K., Ueki A., Iso H., Morita Y. Reduced prepulse inhibition in rats with entorhinal cortex lesions. Behav Brain Res. 134:2002;201-207.
37. Groenewegen H.J., Vermeulen-Van der Zee E., te Kortschot A., Witter M.P. Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience. 23:1987;103-120.
38. Heresco-Levy U., Javitt D.C., Ermilov M., Mordel C., Horowitz A., Kelly D. Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry. 169:1996;610-617.
39. Heresco-Levy U., Javitt D.C., Ermilov M., Mordel C., Silipo G., Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry. 56:1999;29-36.
40. Hirsch S.R., Das I., Garey L.J., de Belleroche J. A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction. Pharmacol Biochem Behav. 56:1997;797-802.
41. Hori T., Subramaniam S., Srivastava L.K., Quirion R. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions. Neuropharmacology. 39:2000;2478-2491.
42. Ishimaru M., Kurumaji A., Toru M. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics Evidence for glutamate hypothesis . Biol Psychiatry. 35:1994;84-95.
43. Javitt D.C., Frusciante M. Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake Implications for schizophrenia and substance abuse . Psychopharmacology. 129:1997;96-98.
44. Javitt D.C., Sershen H., Hashim A., Lajtha A. Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide. Neuropsychopharmacology. 17:1997;202-204.
45. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 148:1991;1301-1308.
46. Javitt D.C., Zylberman I., Zukin S.R., Heresco-Levy U., Lindenmayer J.P. Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry. 151:1994;1234-1236.
47. Jay T.M., Burette F., Laroche S. Plasticity of the hippocampal- prefrontal cortex synapses. J Physiol Paris. 90:1996;361-366.
48. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia . Neuropsychopharmacology. 20:1999;201-225.
49. Kato K., Shishido T., Ono M., Shishido K., Kobayashi M., Niwa S. Glycine reduces novelty- and methamphetamine-induced locomotor activity in neonatal ventral hippocampal damaged rats. Neuropsychopharmacology. 24:2001;330-332.
50. Kato K., Shishido T., Ono M., Shishido K., Kobayashi M., Suzuki H., et al. Effects of phencyclidine on behavior and extracellular levels of dopamine and its metabolites in neonatal ventral hippocampal damaged rats. Psychopharmacology. 150:2000;163-169.
51. Keith V.A., Mansbach R.S., Geyer M.A. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry. 30:1991;557-566.
52. Kretschmer B.D., Koch M. Role of the strychnine-insensitive glycine binding site in the nucleus accumbens and anterodorsal striatum in sensorimotor gating A behavioral and microdialysis study . Psychopharmacology. 130:1997;131-138.
53. Krystal J.H., D'Souza D.C., Petrakis I.L., Belger A., Berman R.M., Charney D.S., et al. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry. 7:1999;125-143.
54. Kumari V., Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia A critical evaluation of current evidence and directions for future research . Psychopharmacology. 162:2002;97-101.
55. Kumari V., Soni W., Mathew V.M., Sharma T. Prepulse inhibition of the startle response in men with schizophrenia Effects of age of onset of illness, symptoms, and medication . Arch Gen Psychiatry. 57:2000;609-614.
56. Le Pen G., Gaudet L., Mortas P., Mory R., Moreau J.L. Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia. Psychopharmacology. 161:2002;434-441.
57. Le Pen G., Grottick A.J., Higgins G.A., Martin J.R., Jenck F., Moreau J.-L. Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats Further evaluation of an animal model of schizophrenia . Behav Pharmacol. 11:2000;257-268.
58. Le Pen G., Moreau J.L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia. Reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology. 27:2002;1-11.
59. Leumann L., Feldon J., Vollenweider F.X., Ludewig K. Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry. 52:2002;729-739.
60. Lipska B.K., Chrapusta S.J., Egan M.F., Weinberger D.R. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse. 20:1995;125-130.
61. Lipska B.K., Jaskiw G.E., Weinberger D.R. The effects of combined prefrontal cortical and hippocampal damage on dopamine-related behaviors in rats. Pharmacol Biochem Behav. 48:1993;1053-1057.
62. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage A potential animal model of schizophrenia . Neuropsychopharmacology. 9:1994;67-75.
63. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
64. Lipska B.K., Weinberger D.R. Delayed effects of neonatal hippocampal damage on haloperidol-induced stereotypic behaviors in the rat. Dev Brain Res. 75:1993;213-222.
65. Lipska B.K., Weinberger D.R. To model a psychiatric disorder in animals Schizophrenia as a reality test . Neuropsychopharmacology. 23:2000;223-239.
66. Liu D., Diorio J., Day J.C., Francis D.D., Meaney M.J. Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat Neurosci. 3:2000;799-806.
67. Malandro M.S., Kilberg M.S. Molecular biology of mammalian amino acid transporters. Annu Rev Biochem. 65:1996;305-336.
68. Meador-Woodruff J.H., Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Res Rev. 31:2000;288-294.
69. Myhrer T. Selective lesions in the temporal-hippocampal region of the rat Effects on acquisition and retention of a visual discrimination task . Behav Neural Biol. 58:1992;8-15.
70. Myhrer T., Paulsen R.E. Memory dysfunction following disruption of glutamergic systems in the temporal region of the rat Effects of agonistic amino acids . Brain Res. 599:1992;345-352.
71. Nilsson M., Carlsson A., Carlsson M.L. Glycine and D-serine decrease MK-801-induced hyperactivity in mice. J Neural Transm. 104:1997;1195-1205.
72. Ohno M., Watanabe S. D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats. Eur J Pharmacol. 318:1996;267-271.
73. Oranje B., Van Oel C.J., Gispen-De Wied C.C., Verbaten M.N., Kahn R.S. Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol. 22:2002;359-365.
74. Parwani A., Duncan E.J., Bartlett E., Madonick S.H., Efferen T.R., Rajan R., et al. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry. 47:2000;662-669.
75. Pitkanen A., Pikkarainen M., Nurminen N., Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann N Y Acad Sci. 911:2000;369-391.
76. Rakic P., Bourgeois J.P., Goldman-Rakic P.S. Synaptic development of the cerebral cortex Implications for learning, memory, and mental illness . Prog Brain Res. 102:1994;227-243.
77. Reijmers L.G., Vanderheyden P.M., Peeters B.W. Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens. Eur J Pharmacol. 272:1995;131-138.
78. Riekkinen P. Jr, Ikonen S., Riekkinen M. Tetrahydroaminoacridine, a cholinesterase inhibitor, and D-cycloserine, a partial NMDA receptor-associated glycine site agonist, enhances acquisition of spatial navigation. Neuroreport. 9:1998;1633-1637.
79. Sams-Dodd F., Lipska B.K., Weinberger D.R. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology. 132:1997;303-310.
80. Schroeder H., Grecksch G., Becker A., Bogerts B., Hoellt V. Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion. Psychopharmacology. 145:1999;61-66.
81. Schuster G.M., Schmidt W.J. D-cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task. Eur J Pharmacol. 224:1992;97-98.
82. Schwarzkopf S.B., Mitra T., Bruno J.P. Sensory gating in rats depleted of dopamine as neonates Potential relevance to findings in schizophrenic patients . Biol Psychiatry. 31:1992;759-773.
83. Sirvio J., Ekonsalo T., Riekkinen P. Jr, Lahtinen H., Riekkinen P. Sr. D-cycloserine, a modulator of the N-methyl-D-aspartate receptor, improves spatial learning in rats treated with muscarinic antagonist. Neurosci Lett. 146:1992;215-218.
84. Smith K.E., Borden L.A., Hartig P.R., Branchek T., Weinshank R.L. Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron. 8:1992;927-935.
85. Steinpreis R.E. The behavioral and neurochemical effects of phencyclidine in humans and animals Some implications for modeling psychosis . Behav Brain Res. 74:1996;45-55.
86. Swerdlow N.R., Bakshi V., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther. 279:1996;1290-1299.
87. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat Current knowledge and future challenges . Psychopharmacology. 156:2001;194-215.
88. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 22:1995;27-34.
89. Swerdlow N.R., Taaid N., Halim N., Randolph E., Kim Y.K., Auerbach P. Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats A parametric assessment . Neuroscience. 96:2000;523-536.
90. Tamminga C.A., Buchanan R.W., Gold J.M. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol. 13:(suppl 3):1998;S21-S26.
91. Tanii Y., Nishikawa T., Hashimoto A., Takahashi K. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J Pharmacol Exp Ther. 269:1994;1040-1048.
92. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol. 42:2002;165-179.
93. Van Groen T., Wyss J.M. Extrinsic projections from area CA1 of the rat hippocampus Olfactory, cortical, subcortical, and bilateral hippocampal formation projections . J Comp Neurol. 302:1990;515-528.
94. Varty G.B., Higgins G.A. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology. 122:1995;15-26.
95. Wan F.J., Swerdlow N.R. The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat. Neuroscience. 76:1997;715-724.
96. Weinberger D.R. The biological basis of schizophrenia New directions . J Clin Psychiatry. 58:(suppl 10):1997;22-27.
97. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry. 45:1999;395-402.
98. Wolterink G., Daenen L.E., Dubbeldam S., Gerrits M.A., van Rijn R., Kruse C.G., et al. Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders. Eur Neuropsychopharmacol. 11:2001;51-59.
99. Wood G.K., Marcotte E.R., Quirion R., Srivastava L.K. Strain differences in the behavioural outcome of neonatal ventral hippocampal lesions are determined by the postnatal environment and not genetic factors. Eur J Neurosci. 14:2001;1030-1034.
100. Yamada S., Harano M., Annoh N., Nakamura K., Tanaka M. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats. Biol Psychiatry. 46:1999;832-838.